NewsRoom Articles - Page 201 of 592

WednesdayJan 12, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Celebrates Productive Year for Blood Pressure Drug Solution with Eye on Advancing Clinical Studies in 2022

Lexaria Bioscience’s ongoing human clinical studies for its patented and trademarked DehydraTECH technology have yielded progressively optimistic results in 2021 regarding DehydraTECH’s ability to provide effective solutions for the cardiovascular industry DehydraTECH is being studied for its capacity to improve CBD’s ability to reduce high blood pressure in a rapid and sustainable manner that exceeds the ability of a generic CBD formulation DehydraTECH-CBD underwent three human clinical studies in 2021 that examined its ability to reduce arterial stiffness and blood pressure without creating unintended negative consequences A fourth, more comprehensive study was approved at year’s end, as the next step…

WednesdayJan 12, 2022 4:20 am

420 with CNW — Eight Marijuana Trends Likely to Play Out in 2022

Marijuana industry executives should pay attention to both positive and negative trends in the industry this year. While some will be a continuation from last year, some will be new to the industry. Below is a list of some trends to be on the lookout for this year. More states will legalize cannabis. More states are expected to legalize cannabis this year, including Delaware, Maryland and Rhode Island, which may legalize the herb for recreational use. States such as North Carolina, South Carolina, Kansas and Mississippi are also expected to legalize cannabis for medical use. However, the federal government’s stance…

TuesdayJan 11, 2022 4:20 pm

420 with CNW — Colorado Governor Signs 1,300 Marijuana Pardons

America’s cannabis sector may have generated billions of dollars and created hundreds of thousands of new jobs, but its most significant achievement has been alleviating the effects of the drug war. Ostensibly started to reduce drug abuse rates and hit the criminal enterprises behind the drug trade where it hurts most — their wallets — the war on drugs failed to achieve its objectives and instead ruined plenty of lives. As a wave of drug reform sweeps across the country, several state leaders have been working to mitigate the disproportionate effects of the drug war and give the victims a new…

TuesdayJan 11, 2022 10:32 am

Q3 Report Notes Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Revenue Growth of 93 percent YOY

Red White & Bloom Brands is a cannabis multi-state operator building on opportunities in Michigan, Florida, Illinois, California, Arizona, Oklahoma and Massachusetts to create a synergistic portfolio throughout North America RWB is also building its hemp-based CBD products retail throughout the United States and into international markets The company has released its third quarter financial report on revenue growth, operational development and progress in finalizing additional agreements The report notes revenues grew from $6.1 million to $11.8 million year-over-year, largely as the result of its acquisition of its premium Platinum Vape The company anticipated having 30 grow pods in place…

TuesdayJan 11, 2022 4:20 am

420 with CNW — Study Finds Cannabis Decriminalization Decreases Racial Disparities, Arrests

A new study has found that cannabis decriminalization causes a reduction in arrests for possession as well as decreases racial disparities in other arrests. The University of California-San Diego researchers who conducted the study obtained data from the FBI Uniform Crime Report for their research. The researchers assessed data from 37 states, which was collected between 2000 and 2019, to determine the impact of policies to decriminalize the herb. In their paper, the researchers stated that minorities often bore the burden of the unequal enforcement of laws on drugs, explaining that in the United States, Blacks were more likely to…

MondayJan 10, 2022 4:20 pm

420 with CNW — Governors Celebrate 2021 Cannabis Reforms as 2022 Gets Underway

The past couple of years have been good for the cannabis industry. The industry managed to weather the coronavirus pandemic much better than other sectors, keeping most cannabis employees working and selling even more cannabis products than before the pandemic. However, the best developments have been on the legal side. Federal lawmakers are working on passing cannabis legislation at the federal level, and several states passed some form of cannabis legalization. Now that 2021 has finally run its course, let’s look at some of the most prominent marijuana reform accomplishments of the year. Connecticut, which still has a completely green…

MondayJan 10, 2022 12:47 pm

CannabisNewsWire Recaps NCIA’s 7th Annual Cannabis Business Summit & Expo

To great acclaim, the National Cannabis Industry Association (“NCIA”) held its 7th Annual Cannabis Business Summit & Expo at San Francisco’s Moscone Center on December 15-17, 2021. As the oldest and largest trade association representing legal cannabis businesses, NCIA gathered together more than 125 expert speakers in over 80 educational sessions, as well as hundreds of exhibitors from across the cannabis ecosystem, for the industry’s most influential B2B event and trade show. Attendees from across the country were welcomed by San Francisco Mayor, London Breed. Her opening address honored the 30th anniversary of the Proposition P ballot initiative, which was…

MondayJan 10, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Independent Review Board Approval for Its Most Ambitious, Comprehensive Human Study Yet

Lexaria has received approval from the Independent Review Board for its DehydraTECH-CBD Human Clinical HYPER-H21-4 study The approval signals the company has taken the appropriate steps to protect the rights and welfare of human subjects participating in its fourth human study HYPER-H21-4 should "de-risk" outcomes prior to Lexaria's planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease Previous studies – HYPER-H21-1 and HYPER-H21-2 – have evidenced a remarkable, rapid, and safe drop in blood pressure with DehydraTECH-CBD A little less than two months after Lexaria Bioscience (NASDAQ: LEXX) announced…

MondayJan 10, 2022 4:20 am

420 with CNW — Canadian Cannabis Executives Share Their Industry Policy Reform Wishlists for 2022

Last year was a mixed bag of a year for Canadian marijuana investors. Speculation about the future of the sector fluctuated wildly as talks about federal legalization heated up in the United States and recreational cannabis prices reached historic lows. Additionally, players in the Canadian cannabis space are waiting with bated breath for the three-year review of the country’s cannabis legislation by federal lawmakers. The review began in December 2021, and the health minister will present the department’s findings and recommendations in 2023. In the interim, industry leaders have a few policy changes in mind that they would like to…

FridayJan 07, 2022 4:20 pm

420 with CNW — Study Explores Why Individuals Use Marijuana During Pregnancy or While Lactating

A new study has found that people who use marijuana during lactation or pregnancy use it to manage pre-existing conditions such as insomnia and mental health conditions, as well as pregnancy-related symptoms, including nausea and vomiting. Dr. Meredith Vanstone, one of the authors of the study, stated that their findings didn’t resonate as much with evidence on motives for marijuana use that have been identified in nonpregnant populations, which proposed that reasons for the herb’s use during lactation and pregnancy were unique. Vanstone explained that the reasons for the herb’s use that had been provided by the study’s participants closely…